Finance

Lists
CUV:ASX
Clinuvel Pharmaceuticals Ltd
7,94 A$
+0,13%
(+0,010) 1D
9 հոկ, 16:10:30 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Open
7,92 A$
High
8,05 A$
Low
7,80 A$
Mkt. cap
400,87 մլն
Avg. vol.
152,74 հզր
Volume
113,35 հզր
Dividend
0,63%
Quarterly dividend
0,01 A$
Ex-dividend date
03 սեպ, 2026 թ.
P/E ratio
12,33
52-wk high
13,48 A$
52-wk low
7,80 A$
EPS
0,64 A$
Shares outstanding
50,49 մլն
No. of employees
16
Open
7,92 A$
High
8,05 A$
Low
7,80 A$
Mkt. cap
400,87 մլն
Avg. vol.
152,74 հզր
Volume
113,35 հզր
Dividend
0,63%
Quarterly dividend
0,01 A$
Ex-dividend date
03 սեպ, 2026 թ.
P/E ratio
12,33
52-wk high
13,48 A$
52-wk low
7,80 A$
EPS
0,64 A$
Shares outstanding
50,49 մլն
No. of employees
16
News stories
From web sources and news partners
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
18,47 մլն
18,47 մլն
28,55 մլն
28,55 մլն
Cost of goods sold
2,28 մլն
2,28 մլն
5,62 մլն
5,62 մլն
Cost of revenue
2,28 մլն
2,28 մլն
5,62 մլն
5,62 մլն
Research and development expenses
1,70 մլն
1,70 մլն
7,35 մլն
7,35 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,96 մլն
6,96 մլն
2,83 մլն
2,83 մլն
Operating expense
9,42 մլն
9,42 մլն
9,42 մլն
9,42 մլն
Total operating expenses
11,71 մլն
11,71 մլն
15,04 մլն
15,04 մլն
Operating income
6,76 մլն
6,76 մլն
13,51 մլն
13,51 մլն
Other non operating income
-
-
322,45 հզր
322,45 հզր
EBT including unusual items
7,29 մլն
7,29 մլն
16,54 մլն
16,54 մլն
EBT excluding unusual items
7,29 մլն
7,29 մլն
16,54 մլն
16,54 մլն
Income tax expense
2,07 մլն
2,07 մլն
4,80 մլն
4,80 մլն
Effective tax rate
28,39%
28,39%
29,03%
29,03%
Other operating expenses
-1,24 հզր
-1,24 հզր
1,24 հզր
1,24 հզր
Net income
5,22 մլն
5,22 մլն
11,74 մլն
11,74 մլն
Net profit margin
28,28%
28,28%
41,11%
41,11%
Earnings per share
-
-
-
-
Interest and investment income
2,63 մլն
2,63 մլն
3,87 մլն
3,87 մլն
Interest expense
-1,28 մլն
-1,28 մլն
-
-
Net interest expenses
1,35 մլն
1,35 մլն
3,87 մլն
3,87 մլն
Depreciation and amortization charges
250,02 հզր
250,02 հզր
-250,02 հզր
-250,02 հզր
EBITDA
7,01 մլն
7,01 մլն
13,55 մլն
13,55 մլն
Gain or loss from assets sale
-
-
28,62 հզր
28,62 հզր
AI content may include mistakes. Learn more
Google Apps